… ProQR Strengthens its Scientific Advisory Board with the … SAB. Science is at the core of everything we do at ProQR, and with this group as our key advisors we can be more … of success that will be invaluable as we advance our R&D programs and our broader RNA technologies, including the …
… ProQR Announces Closing of Underwritten Public Offering of … and CAMBRIDGE, Mass., Sept. 11, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical … securities laws of any such state or jurisdiction. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR Announces Closing of Underwritten Public Offering of … share. All of the shares are being offered by ProQR. The closing included the full exercise of the … securities laws of any such state or jurisdiction. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR Announces Clearance of IND Application to Start … affected by this devastating disease,“ said Noreen R. Henig, MD, Chief Medical Officer of ProQR. “Importantly, this trial is the first in ProQR’s …
… ProQR Therapeutics and Yarrow Biotechnology, an RTW … sectors, and ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through the … newly created by RTW, has in-licensed exclusive rights to ProQR’s antisense oligonucleotide technology (ASO) to develop …